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Pancreatic tumorsAbstract Objective: The purpose of this study was to determine the role of multidetector com-
puted tomography (MDCT) in evaluation and prediction of pancreatic tumors resectability.
Patients and methods: The study included 20 patients who had pancreatic masses, 16 males and 4
females, and their age range was 30–70 years with a mean age of 58.0 years. All the patients under-
went non-contrast and contrast enhanced Multi-slice CT using a 16-slice machine. The gold stan-
dard for diagnosis was histopathology and operative data.
Results: Adenocarcinoma as reported by pathological studies was found in 8 patients, cyst adeno-
carcinoma in one patient, inﬁltrative adenocarcinoma in 2 patients, intraductal papillary mucinous
tumor in 2 patients, mucinous cyst adenocarcinoma in one patient, pancreatic pseudo cyst in 2
patients and mucinous cystadenoma in 4 patients. According to MDCT criteria 6 patients were con-
sidered suitable for tumor resection and 14 patients were considered inoperable with unresectable
tumor, one out of the 6 operable patients was unresectable during operation due to the invasion
of the superior mesenteric vein with inﬁltration of the mesenteric root.
Conclusion: Contrast-enhanced multiphase pancreatic imaging by multislice computerized tomog-
raphy (MSCT) with its postprocessing techniques represents the image of choice for diagnosis and
predicting pancreatic masses and resectability.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine.Open access under CC BY-NC-ND license.1. Introduction
Imaging of the pancreas is challenging because of its anatomic
location in the retroperitoneum and its intricate relationship
with major blood vessels and bowel. Computed tomography
(CT) has been the initial imaging modality of choice for eval-
uation of pancreatic pathology (1).
Pancreatic cancer is the fourth most frequent cause of can-
cer-related death. The incidence is increasing and the overall
survival has been altered a little in recent years (2). The overall
5 years survival rate of pancreatic cancer ranges from 0.4% to
Table 1 Age and sex frequency distribution of the studied 20
patients with pancreatic mass.
Age Female Males Total Percentage (%)
>30–40 0 0 1 5% 1 5
>40–50 2 10% 3 15% 5 25
>50–60 2 10% 10 50% 12 60
>60–70 0 0% 2 10% 2 10
Total 4 20% 16 80% 20 100
Table 2 Show different multislice CT manifestations of the
pancreatic masses detected in the studied 20 patients.
Multislice CT manifestation Number of the patients Percentage (%)
Margin
Ill-deﬁned 12 60
Well-deﬁned 8 40
Density pattern
Mixed 11 55
Hypodense 7 35
Hyperdense 2 10
Pattern of enhancement
Homogenous 11 55
Heterogeneous 9 45
Calciﬁcation 1 5
(A) Axial non contrast CT 
(C) Axial contrast enhanced CT at
Portal phase at higher level 
(D
Fig. 1 (A–D) 62 year old male patient presented bwithy jaundice
pancreatic head mass (white arrow). (B & C)-Post-contrast CT scan sh
mass (white arrow), marked dilatation of the CBD and the pancreatic
(D)-Curved multiplanar reformatting shows dilated intrahepatic bile du
arrow). Excised Biopsy revealed: pancreatic adenocarcinoma.
310 M.A. Dawoud et al.4%, the lowest for any cancer. Currently surgical resection of-
fers the best chance of cure, however more than 80% of pa-
tients present with advanced and unresectable disease. The
key to increase resection rates of pancreatic cancer lies with
early diagnosis (3).
Recent improvements in imaging techniques have made it
possible to improve the diagnostic accuracy for detection, stag-
ing, and indicating surgical resectability of pancreatic cancer
(4). Improvements in CT technology during the past decade,
with fast image acquisition and improved spatial resolution,
have increased the accuracy of CT for lesion detection and
characterization. Axial CT images are not sufﬁcient to demon-
strate the complex anatomy of the pancreas and have made it
mandatory to have multiphasic and multiplanar imaging of the
pancreas (5).
Multislice CT is the most efﬁcient non invasive technique in
the assessment of pancreatic cancer, multislice CT allows
excellent visualization of the pancreatic cancer during the dif-
ferent stages of contrast enhancement, thereby facilitates
detection of small pancreatic lesions and evaluation of peri-
pancreatic structures. 3D multiplanar reformatted images
can be used to solve different diagnostic problems and to help
communicate ﬁndings to clinicians (6).
The aim of this study was to determine the role of multide-
tector computed tomography (MDCT) in evaluation and pre-
diction of pancreatic tumors resectability.(B) Axial contrast enhanced CT at
portal phase 
) Curved multiplanar reformatting
projection 
, vomiting and epigastric pain (A)-Pre-contrast CT scan shows
ows a small ill deﬁned relatively mildly enhanced pancreatic head
duct (black arrows) also GB is markedly distended (block arrow).
cts and CBD (black arrows) that end abruptly by the mass (white
(C) Curved multiplanar reformatting projection
(A) Axial contrast enhanced CT at
portal phase 
(B) Axial contrast enhanced CT at
portal phase at lower level 
Fig. 2 (A–C) 60 year-old-patient presented with abdominal pain and vomiting. Axial contrast enhanced CT (A & B) shows pancreatic
tail complex cystic & solid mass (black arrow) (C) multiplanar reformatting shows pancreatic tail mass (black arrows) Excised Biopsy
revealed: cyst adenocarcinoma.
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2.1. Population
This study included twenty patients with clinical and labora-
tory ﬁndings of pancreatic mass (16 males and 4 females) or
as a follow-up study for pancreatic cancer referred to the CT
unit in Tanta university hospital in the period from February
2012 to August 2013 and their ages ranging from 30 to 70 years
with mean age: 58.0 years ± 8.2 [SD]. Patients with chronic re-
nal impairment (high serum creatinine) or previous allergy to
the contrast media were excluded from the study. This study
was approved by the ethics committee of Tanta Faculty of
Medicine; an informed consent was obtained from all patients
after full explanation of the beneﬁts and risks of the procedure.
2.2. Methods
All patients were subjected to careful history taking, general
and abdominal examination, laboratory and serological exam-
inations, abdomino-pelvic ultrasound and multidetector com-
puted tomography.2.3. Abdomino-pelvic ultrasound
Trans-abdominal ultrasound was the initial test. Ultrasono-
graphic examination was done for all patients searching for
signs of pancreatic mass. Scanning was done using 3.5 and
5 MHz curvilinear transducers (B-K Medica) after an over-
night fast. The liver, gallbladder, pancreas, intrahepatic and
extrahepatic bile ducts were evaluated. Any additional ﬁndings
namely, ascites, enlarged lymph nodes were also evaluated.
2.4. MDCT technique
This study was performed using a 16 slice multi detector CT
(Somatom, E-motion 16, Siemens Healthcare; Germany).
Low residue diet was prescribed 24 h before the procedure
and the patient was instructed to come to CT unit after com-
pleting fasting for about 4–6 h before examination. Reassur-
ance and brief explanation of the procedure to the patient
were given. All patients were examined in supine position, each
patient was instructed to remain stable and do not move dur-
ing examination. Also suspended breathing during scanning
time was important.
3(A) Axial contrast enhanced CT at 
arterial phase.
(B) Axial contrast enhanced CT at 
portal phase
(C) Axial contrast enhanced CT 
at delayed phase.  
Fig. 3 (A–C) 55 year-old-patient presented with abdominal pain and jaundice. Triphasic CT study shows irregular contour of the
pancreas with mixed cystic and solid mass seen inseparable from the pancreatic tail (black arrow) the lesion is hypo attenuated in relation
to enhanced pancreatic parenchyma at arterial phase (A), porto-venous (B) and delayed phase (C). A hypodense focal lesion in right
hepatic lobe showing marginal enhancement (white arrow) Excised Biopsy revealed: mucinous cyst adenocarcinoma.
312 M.A. Dawoud et al.2.4.1. Oral contrast regimen
Opaciﬁcation of the gastrointestinal tract with oral contrast
material was given routinely before CT scanning; one liter of
diluted 2–4% non ionic contrast material was administered
in three divided doses before the examination. The diluted con-
trast was prepared from 20 ml of non ionic contrast completed
by 1000 ml of water, two doses of 400 ml of this diluted con-
trast was given orally 10 and 4 h before the examination and
another 200 ml was given when the patient was on the scanner
before starting the examination. The ﬁrst dose was given to
facilitate ﬁlling of distal small intestine and colon, the second
dose was given to ﬁll the proximal ileum and jejunum and
the third cup was given when the patient is on the scanner to
assure optimal ﬁlling of the stomach and duodenum. Precon-
trast scanning was acquired in all patients; it was performed
from the level of diaphragmatic copula to the level of symphy-
sis pubis for scanning of the whole abdomen.
2.4.2. Post contrast regimen
After the end of precontrast CT examination, post contrast
scan was done after automatic injection of 100 ml non-ionic
iodinated contrast ultravist 300 (300 mg iodine/ml)) at a rate
of 5 ml/s into the antecubital vein, the volume of contrast med-
ium was based on the patients’ weight. The volume of contrast
medium delivered was 2 ml per kg of body weight with an
average of 100–150 ml. The arterial phase starts 20–35 s after
the start of injection of contrast medium. The porto-venousand the delayed phase began 70 and 180 s after initiation of
the contrast injection, respectively then image data were recon-
structed and sent to a workstation.
2.4.3. The scan parameters
The scan parameters are tube current 120 kV and 400 mA,
slice thickness 5 mm, collimation of 0.6 mm, pitch 0.6, 0.6-s
gantry rotation time and table speed of 7.5–10 mm per rota-
tion during a single breath-hold acquisition of 15–25 s.
2.5. Image analysis
Multislice computerized tomography allows examination of
the pancreas with thin slice thickness (1 mm) or less during a
short time of a single breath hold with high quality images.
This allows application of different pancreatic scanning proto-
cols, the best of which is a three phase protocol. The arterial
phase is helpful for detection of hypervascular tumors, and
obtaining CT angiography of peripancreatic vasculature to
determine vascular involvement. The parenchymatous and
portal venous phases are important for detection of hypovas-
cular tumors that represent nearly all pancreatic carcinoma,
and for detection of liver metastasis. Almost all of pancreatic
adenocarcinomas are unresectable. MSCT is useful to prevent
an unnecessary Whipple procedure (resection of the distal
stomach, duodenum, and part or all of pancreas). Any of the
following ﬁndings are CT signs of unresectability: liver metas-
(A) Axial contrast enhanced CT at
 arterial phase.
(B) Axial contrast enhanced CT at
portal phase 
(C) Axial contrast enhanced CT at delayed phase. 
Fig. 4 (A–C) 63 year-old-patient presented with dyspepsia. Triphasic CT study shows well deﬁned lesion with marginal calciﬁcation at
the site of pancreatic tail (white arrow) appears in the arterial (A), venous (B) and delayed phase of the study (C). Right hepatic lobe
hypodense mass with no evident of enhancement in all the phases (block arrow) Excised Biopsy reveled: pancreatic mucinous cyst
adenocarcinoma.
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encasement, venous occlusion, and lymph node enlargement
outside the ﬁeld.
2.6. Statistical analysis
The diagnostic efﬁcacy of MDCT in the prediction of pancre-
atic masses and signs of unresectability was evaluated and
compared with histopathological and surgical ﬁndings which
were considered the gold standard of reference. Data entry
was done by SPSS version 16 and analyzed by the same soft-
ware. A P value <0.05 was considered signiﬁcant.
3. Results
Twenty patients with pancreatic masses were evaluated during
the period from February 2012 to August 2013 with the multi
detector CT study. The ﬁnal diagnosis obtained depends on
histopathological biopsy and operative data.
This study included 20 patients (16 males and 4 females),
with the commonest age of pancreatic masses between 50
and 60 years as shown in Table 1.
As regards multislice CT manifestations of the pancreatic
masses, well deﬁned margins are detected in twelve cases, while
the remaining eight cases appeared with ill deﬁned margins,seven cases appeared hypodense, and two cases appeared
hyperdense. Eleven patients showed homogenous enhance-
ment, nine patients showed heterogeneous enhancement. Only
one case showed calciﬁcation, these data are shown in Table 2,
Figs. 1–5.
Other multislice CT ﬁndings associated with pancreatic
masses were intrahepatic biliary radicals dilatation which ap-
peared in nine patients, dilated pancreatic duct appeared in ﬁve
patients, six patients showed dilated common bile duct, hepatic
metastasis was detected in ﬁve patients, two patients showed
duodenal invasion, and four patients showed enlarged lymph
nodes. Two patients showed ascites and two patients showed
vascular invasion. In addition to the previously detected ﬁnd-
ing, other associated extra pancreatic lesions were observed on
the multislice CT study. There were eight patients with chest
manifestation, one patient showed adnexal cystic lesion and
one patient showed osteolytic bone lesion and this is shown
in Table 3.
The studied 20 patients were subjected to histopathological
study. Intra-operative tru-cut biopsy was done for 6 patients;
percutaneous CT guided needle biopsy was done for 6 patients,
percutaneous US guided biopsy was done for 5 patients, and
ERCP biopsy was done in the remaining 3 patients. Pancreatic
ductal adenocarcinoma appeared in eight patients, cyst adeno-
carcinoma in one patient, inﬁltrative periampullary in two
(A) Axial contrast enhanced CT at
arterial phase. 
(B) Axial contrast enhanced CT at
arterial phase at higher level 
(D) Axial contrast enhanced CT
at delayed phase.  
(C) Axial contrast enhanced CT
at venous phase.  
Fig. 5 (A–D) 53 year-old-patient presented with jaundice & abdominal pain. Triphasic CT study shows bulky head of pancreas with small
hypodense focal area (black arrow), dilated CBD & prominent pancreatic duct (white arrow) seen in arterial (A & B), venous (C) and
delayed (D) phases, also small peripancreatic and para-aortic lymph nodes (curved arrow).
Table 3 Show different multislice CT ﬁndings associated with
pancreatic masses detected in the studied 20 patients.
CT ﬁnding Number of
the patient
Percentage
(%)
I.H.B.R.D. 9 45
Dilated pancreatic duct 5 25
Dilated C.B.D. 6 30
Hepatic metastasis 5 25
Duodenal invasion 2 10
Enlarged L.Ns 4 20
Ascites 2 10
Peripancreatic vascular invasion 2 10
Chest lesions
Pulmonary 6 30
d Inﬂammatory reactions 1 5
d Deposits 3 15
d Atelectatic bands 1 5
d Pneumonic Patches 1 5
Pleural eﬀusion 2 10
Adnexal cystic lesions 1 5
Osteolytic bone lesion 1 5
314 M.A. Dawoud et al.patients, intraductal papillary mucinous tumor in two patients,
mucinous cyst adenocarcinoma in one patient, mucinous cyst
adenoma in four patients and pseudo pancreatic cyst in two
patients as shown in Table 4.
According to predicting resectability by using the multislice
CT on the studied 20 patients, 6 patients were consideredsuitable for tumor resection and 14 patients were considered
inoperable with unresectable tumor, one out of the 6 operable
patients was unresectable during operation due to the invasion
of the superior mesenteric vein with inﬁltration of the mesen-
teric root, the resected Table 5 pancreatic masses show free
surgical margin (negative for malignant cells) on histopathol-
ogy results as shown in Tables 5 and 6.
4. Discussion
When pancreatic mass is suspected clinically, various imaging
modalities have been employed for further evaluation of this
mass. The use of non-invasive techniques including US and
CT permits a more frequent diagnosis of pancreatic neoplastic
lesions (7).
Recent improvements in imaging techniques have made it
possible to improve the diagnostic accuracy for detection, stag-
ing, and indicating surgical resectability of pancreatic cancer
(8).
Multislice CT is the most efﬁcient non invasive technique in
the assessment of pancreatic cancer, it allows excellent visual-
ization of the pancreatic cancer during the different stages of
contrast enhancement, thereby facilitates detection of small
pancreatic lesions and evaluation of peripancreatic structures
(9).
In our study, our data were obtained from clinical examina-
tion, real time ultrasonography, multislice CT and ﬁnally his-
topathological examination.
In this study, pancreatic neoplasms are more common in
males 80% than females 20%, this is in agreement with Jemal
Table 4 Histopathological diagnosis of the studied 20 patients
with pancreatic mass.
Pathology Number of
the patients
Percentage
(%)
Adenocarcinoma 8 40
Cyst adenocarcinoma 1 5
Inﬁltrative periampullary 2 10
Intraductal papillary mucinous tumor 2 10
Mucinous cyst adenocarcinoma 1 5
Mucinous cystadenoma 4 20
Pseudo pancreatic cyst 2 10
Table 5 MDCT prediction of the resectability in 20 patients
with pancreatic mass.
Prediction of the
resectability
Number of the
patient
Percentage
(%)
Resectable 6 30
Non resectable 14 70
Table 6 MDCT resectability correlated with surgical and
histopathological results.
Prediction of the resectability Number of
the patient
Percentage
(%)
P value
MDCT resectable 6 30 <0.05
Surgical resectable 5 25
Histopathological resectable 5 25
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pancreatic neoplasm is greater in men than in women and in
contrast with John et al. (11) who found that recently more
women are developing the pancreatic malignancy.
The age group mostly affected by pancreatic neoplasm in
this study is 60–70 years. John et al. (11) found that those aged
60 < 80 years are the most affected group with pancreatic neo-
plasms and uncommon in those younger than 40 years.
In this study, pain is the most common complaint. It ac-
counts for 60% of the examined patients. Jaundice was the sec-
ond common complaint in 45% of patients. This is similar to
the statement of Takhar et al. (3) and differs from the result of
Russel et al. (12) who stated that obstructive jaundice was seen
in 85% of patients. John et al. (11) also stated that obstructive
jaundice is seen in 75% of patients and about 46% of their pa-
tients were presented with pain and jaundice.
In this study the size of the masses in 4 patients was more
than 7 cm, two of these patients had cystic and one of them
had solid mass. In 8 patients the size of the mass ranged from
3 to 7 cm. The last 8 patients had small mass less than 3 cm,
Tatli et al. (13) found that the mean largest dimension is
6.0 · 5.0 cm.
In our study multi slice CT could detect the pancreatic
masses in the selected 20 patients resulting in sensitivity of
97.7% in detection of pancreatic masses and resectability.
Scaglion et al. (14) reported sensitivity as high as 90 to 97%
in the detection of pancreatic masses.In our study multislice CT could identify 10 (50%) solid, 8
(40%) cystic and 2 (10%) mixed lesions. Curry et al. (15) stated
that cystic pancreatic tumor accounts for only 1% of the pan-
creatic neoplasm.
Becker and Stommer (16) reported that 60% of pancreatic
tumors occupied the head of pancreas, 10% the body, about
5% the tail and the remaining 25% were diffusely involved,
in our study 45% of tumors occupied the head of the pancreas,
25% the body, 5% the tail and 10% the body and tail, so it
was logical to have 45% of patients with a clinical history of
jaundice because 45% of the masses were in pancreatic head.
In our study adenocarcinoma as reported by pathological
studies was the most common pathological ﬁnding in about
40% of the patients, this is in agreement with Cascinu et al.
(17) who stated that adenocarcinoma accounts for up to
70% of the pancreatic malignancies.
In this study, the most common reported associated extra
pancreatic ﬁnding is dilated intra hepatic biliary radical which
is seen in 9 patients (30%), this sign is seen in patients with
head masses. John et al. (11) stated that ductal dilatation oc-
curs in 58% of patients with pancreatic neoplasm and ductal
dilatation proximal to the obstructing tumors was detected
in approximately 88% of pancreatic head tumors and 60%
of body tumors.
Liver metastasis could be detected by multi slice CT in 5 pa-
tients (25%). This comes in agreement with Murﬁtt (18) who
stated that metastasis to the liver occurs in approximately
17–55% of the patients.
Chest distant metastatic manifestation was the most com-
mon associated extra pancreatic ﬁnding in the current study.
This was reported in 35% of the patients and osteolytic bony
lesion in 5% of the patient .This comes in agreement with the
statement of Kloppel (8) who stated that metastasis to lung,
pleura and bone is only seen in advanced tumor stages.
In the absence of distal distant metastasis, vascular invasion
is the single most common criterion detected in patients with
pancreatic lesions. Detection of vascular invasion is a key to
the surgeon in preoperative planning because the posterior lat-
eral surface of the portal and superior mesenteric vein if in-
vaded can be evaluated by surgical procedure as advanced
pancreatic tumor (Vargas et al. (19)).
In our study we reported 14 (70%) patients with pancreatic
cancer who had unresectable tumors and 6 (30%) patients had
resectable tumors, and the causes of unresectability were hepa-
tic metastasis, distant lymph nodes involvement, vascular inva-
sion and ascites. This comes in agreement with Li et al. (20)
who stated that about 25–30% of patients have resectable dis-
ease at the time of presentation. Our study has limitations,
ﬁrstly only limited number of resectable tumor cases was as-
sessed and secondly no patients with unresectable tumors un-
dergo laparotomy.
In conclusion, Contrast-enhanced multiphase pancreatic
imaging by multislice computerized tomography (MSCT) with
its postprocessing techniques represents the image of choice
for diagnosis and predicting pancreatic masses and
resectability.
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